News

11 September 2007
Novo Nordisk is rated supersector leader in the 2007 Dow Jones Sustainability Indexes

11th July 2007
Advice for travellers on international flights carrying insulin supplies

2nd July 2007
Novo Nordisk increases transparency on clinical trials

13th June 2007
New Economist Intelligence Unit research highlights the economic cost of diabetes to developed and developing countries

1 May 2007
Novo Nordisk signs agreement on CO₂ reduction - a major part of the company’s future electricity consumption in Denmark will be supplied by wind turbines.

Important: Novo Nordisk packaging changes

Changes in the appearance of the packaging of Novo Nordisk insulins and hormone therapy products have been phased in since 2002. Product names are clearly displayed and no changes have been made to the medicine preparations. Please read the label text to identify your medication prior to use.

- For insulin products click here
- For hormone therapy products click here

Changing Diabetes Bus World Tour

Travelling across the globe, the Novo Nordisk changing diabetes bus aims to raise awareness to help overcome one of the world's most pressing healthcare crises.

The bus visited Australia in January 2007.

Product Discontinuation News

At Novo Nordisk, review of our product portfolio is ongoing. This means several products are being discontinued.

Simplifying our range of therapies allows us to focus on continuously offering the best possible treatment solutions and support to people with diabetes and healthcare professionals.

For further information click here

For New Zealand Healthcare Professionals

If you would like information on the Novo Nordisk New Zealand Diabetes Grant Scheme 2008. Please click here